stoxline Quote Chart Rank Option Currency Glossary
Becton, Dickinson and Company (BDX)
226.8  -1.99 (-0.87%)    05-28 16:00
Open: 227.38
High: 228.39
Volume: 1,249,086
Pre. Close: 228.79
Low: 225.62
Market Cap: 65,547(M)
Technical analysis
2024-05-28 4:51:09 PM
Short term     
Mid term     
Targets 6-month :  276.27 1-year :  284.15
Resists First :  236.53 Second :  243.27
Pivot price 234.39
Supports First :  225.61 Second :  187.71
MAs MA(5) :  231.05 MA(20) :  234.79
MA(100) :  237.97 MA(250) :  249.7
MACD MACD :  -1.7 Signal :  -0.9
%K %D K(14,3) :  6.9 D(3) :  15.4
RSI RSI(14): 34.2
52-week High :  287.32 Low :  225.61
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BDX ] has closed below the lower bollinger band by 10.6%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ BDX ] is to continue within current trading range. Bollinger Bands are 6.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 229.88 - 232.09 232.09 - 233.42
Low: 220.85 - 223.79 223.79 - 225.56
Close: 223.46 - 228.2 228.2 - 231.07
Company Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Headline News

Tue, 28 May 2024
Orion Portfolio Solutions LLC Sells 3,525 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat

Tue, 28 May 2024
Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Orion Portfolio Solutions LLC - Defense World

Tue, 28 May 2024
Becton, Dickinson and Company (NYSE:BDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Tue, 28 May 2024
Becton, Dickinson and Company (NYSE:BDX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Mon, 27 May 2024
Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Advisory Services Network LLC - Defense World

Sat, 25 May 2024
Here's Why We Think Becton Dickinson (NYSE:BDX) Might Deserve Your Attention Today - Yahoo Canada Shine On

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Instruments & Supplies
Shares Out 289 (M)
Shares Float 288 (M)
Held by Insiders 0.3 (%)
Held by Institutions 88 (%)
Shares Short 2,170 (K)
Shares Short P.Month 2,930 (K)
Stock Financials
EPS 4.67
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 88.73
Profit Margin 6.7 %
Operating Margin 16.4 %
Return on Assets (ttm) 3.2 %
Return on Equity (ttm) 5.3 %
Qtrly Rev. Growth 4.5 %
Gross Profit (p.s.) 0
Sales Per Share 68.23
EBITDA (p.s.) 17.54
Qtrly Earnings Growth 20.8 %
Operating Cash Flow 3,760 (M)
Levered Free Cash Flow 3,920 (M)
Stock Valuations
PE Ratio 48.56
PEG Ratio 72
Price to Book value 2.55
Price to Sales 3.32
Price to Cash Flow 17.43
Stock Dividends
Dividend 0.94
Forward Dividend 0
Dividend Yield 0.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android